Mohammad R. Al-Qudimat

Publications (4) View all

• Article: Enucleation for retinoblastoma: the experience of a single center in Jordan.

  Iyad Sultan, Matthew W Wilson, Ibrahim Nawaiseh, Mustafa Mehyar, Saamir Kharma, Mohammed Al-Qudimat, Ribhi Hazin, Arwa Alalami, Imad Jaradat, Maysa Al-Husseini, Ghadeer Abdeen, Carlos Rodriguez-Galindo, Ibrahim Qaddoumi
  [show abstract] [hide abstract]
  ABSTRACT: Despite multiple advances in the management of retinoblastoma, enucleation remains an essential therapeutic modality. We studied patients who underwent enucleation at the King Hussein Cancer Center in Jordan. We retrospectively reviewed medical records of children with retinoblastoma who were treated at our center from June 2002 to February 2008. Twenty-eight eyes from 27 patients were enucleated. Median age at diagnosis was 1.1 years (range, 0.3-6.3 years). Twenty-six eyes (93%) had advanced disease (RE groups IV and V). Seventeen patients (61%) had unilateral retinoblastoma, and 11 (39%) had bilateral retinoblastoma. The median time from diagnosis to enucleation was 0.45 months (range, 0-45 months; mean, 4.4 months) and was longer for patients with bilateral retinoblastoma (median, 2.2 vs. 0.2 months; P = 0.034). Twenty enucleated eyes (71%) did not show high-risk pathologic features. Seventeen eyes with advanced intraocular disease were enucleated at the time of presentation, whereas chemoreduction was attempted for the other 19 eyes with advanced intraocular disease. Enucleation was then recommended for nine (47%) of those eyes. Enucleation at the time of diagnosis was feasible for most patients with advanced disease. Attempted salvage of eyes with advanced disease is justified, particularly in patients with bilateral disease. We were able to salvage almost half of these eyes. We hope our study provides new insights for counseling patients.
  International Ophthalmology 08/2010; 30(4):407-14.
• Article: Family strategies for managing childhood cancer: using complementary and alternative medicine in Jordan.

  Mohammad R Al-Qudimat, Cathy L Rozmus, Nemah Farhan
  [show abstract] [hide abstract]
  ABSTRACT: This paper is a report of a study that examined the use of complementary and alternative medicine therapies among children with cancer in Jordan. Complementary and alternative medicine use by oncology patients has been gaining acceptance in the developed countries and developing countries. Healthcare professionals are becoming increasingly aware that patients use complementary and alternative medicine either covertly or overtly. A descriptive cross-sectional design was used with parents of children with cancer under treatment and follow-up in a paediatric oncology department in Jordan between August 2007 and April 2008. Parents of 69 children with cancer in Jordan were surveyed for their use of complementary and alternative medicine with their children. A total of 65.2% of the sample had used at least one type of complementary and alternative medicine during the course of their child's treatment. The use of biological and nutritional complementary and alternative medicine was 70.5% among the users. Use of body and soul complementary and alternative medicine strategies was reported for 22.2% of the children using complementary and alternative medicine. Twenty per cent of the sample used body movement complementary and alternative medicine for their children. A total of 45.5% of complementary and alternative medicine users perceived benefits in using complementary and alternative medicine for their children with cancer. However, 40% of complementary and alternative medicine users had stopped using complementary and alternative medicine for multiple reasons. Parents used complementary and alternative medicine to support their children's medical treatment and to use all possible methods to cure their children. The reason for parents not using complementary and alternative medicine included not being aware of complementary and alternative medicine. Most of the patients have not discussed the issue of using complementary and alternative medicine with the medical staff.
  Journal of Advanced Nursing 03/2011; 67(3):591-7. · 1.48 Impact Factor
• Article: Clinical nurse coordinators: a new generation of highly specialized oncology nursing in Jordan.

  Mohammad R Al-Qudimat, Sara Day, Tha'er Almomani, Dian Odeh, Ibrahim Qaddoumi
  [show abstract] [hide abstract]
  ABSTRACT: Despite the important role of nurses in a pediatric oncology team, the marginalization of nursing is common, especially in developing countries. At the King Hussein Cancer Center (KHCC) in Jordan, the position of the clinical nurse coordinator (CNC) was created in the pediatric neuro-oncology and ocular oncology services to empower the role of nursing. Our advanced nursing practice is based on the domains of the Strong Model of Advanced Practice, which are direct patient care, support of systems, education, research and publications, and professional leadership. There is strong involvement of the CNC in clinical care, patient education, follow-up, and interdisciplinary collaboration, which has resulted in improved survival, reduced morbidity, and increased compliance of patients and also their successful reintegration into society. The coordination of twinning initiatives and telemedicine activities has helped ensure the quality of treatment and supported research initiatives in the services. Such a positive impact has led to a significant increase in the recruitment of CNCs at KHCC. We propose that the role of nursing be strengthened in developing countries to improve the level of care provided to patients and their families.
  Journal of Pediatric Hematology/Oncology 02/2009; 31(1):38-41. · 1.16 Impact Factor
• Article: The missing links in parents support groups in pediatric oncology in developing countries: The role of clinical nurse coordinators and the Jordanian experience

  Almomani, T. Al-Qudimat, M. Odeh, I. D. Qaddoumi
  Pediatric Blood and Cancer. 10/2006; 49:437.